BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24697705)

  • 1. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
    Zhou Y; Ning Q; Yu DN; Li WG; Deng J
    J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system.
    Ma Y; Li H; Guan S
    Drug Dev Ind Pharm; 2015 Feb; 41(2):177-82. PubMed ID: 25113432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats.
    Choi YA; Yoon YH; Choi K; Kwon M; Goo SH; Cha JS; Choi MK; Lee HS; Song IS
    Biol Pharm Bull; 2015; 38(2):208-17. PubMed ID: 25747979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
    Han HK; Shin HJ; Ha DH
    Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
    Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
    Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral bioavailability of breviscapine after encapsulation in a liposomal formulation.
    Zhong HJ; Deng YJ; Yang BH; Li CL; Du S
    Pharmazie; 2005 Jun; 60(6):475-6. PubMed ID: 15997842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of liposomal breviscapine in brain following intravenous injection in rats.
    Lv W; Guo J; Li J; Huang L; Ping Q
    Int J Pharm; 2005 Dec; 306(1-2):99-106. PubMed ID: 16280216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
    Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
    Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
    Basalious EB; Shamma RN
    Int J Pharm; 2015 Sep; 493(1-2):347-56. PubMed ID: 26241752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells.
    Song CK; Balakrishnan P; Shim CK; Chung SJ; Kim DD
    J Microencapsul; 2011; 28(6):575-81. PubMed ID: 21770706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers.
    Hou J; Wang J; Sun E; Yang L; Yan HM; Jia XB; Zhang ZH
    Drug Deliv; 2016 Nov; 23(9):3248-3256. PubMed ID: 26984338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats.
    Zhu Y; Wang M; Zhang J; Peng W; Firempong CK; Deng W; Wang Q; Wang S; Shi F; Yu J; Xu X; Zhang W
    Arch Pharm Res; 2015 Apr; 38(4):512-21. PubMed ID: 25231341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
    Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
    J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and biodistribution of breviscapine proliposomes in heart.
    Fei X; Chen X; Liang G; Yue-Jian C; Hao W; Ning G; Jia-Bi Z
    J Drug Target; 2009 Jun; 17(5):408-14. PubMed ID: 19555267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poloxamer-based solid dispersions for oral delivery of docetaxel: Differential effects of F68 and P85 on oral docetaxel bioavailability.
    Song CK; Yoon IS; Kim DD
    Int J Pharm; 2016 Jun; 507(1-2):102-8. PubMed ID: 27154250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation.
    Wang X; Guan Q; Chen W; Hu X; Li L
    Drug Des Devel Ther; 2015; 9():1805-13. PubMed ID: 25848217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
    Shao Y; Yang L; Han HK
    Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivesicular liposome formulation for the sustained delivery of breviscapine.
    Zhong H; Deng Y; Wang X; Yang B
    Int J Pharm; 2005 Sep; 301(1-2):15-24. PubMed ID: 16023316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration.
    Zhu Q; Guo T; Xia D; Li X; Zhu C; Li H; Ouyang D; Zhang J; Gan Y
    J Pharm Pharmacol; 2013 Aug; 65(8):1107-17. PubMed ID: 23837579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.